[ WEEKLY GXP BRIEFING ]

What changed in GxP, one Monday at a time.

One item that mattered, the comment windows still open, and a windowed sweep across FDA, EMA, MHRA and Health Canada — with SPEQ’s reading kept visibly separate from the regulator’s facts.

The first issue has not been published yet.

Issues are archived here the moment they are sent. Subscribe below and the next one reaches you on Monday.